Breaking News
Get 50% Off 0
📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-Earnings Read more
Close

Hologic Inc (HOLX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Hologic's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
77.87 +0.18    +0.23%
14:32:40 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 978,273
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 77.39 - 78.11
Hologic 77.87 +0.18 +0.23%

Hologic Inc Company Profile

 
Get an in-depth profile of Hologic Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

6944

Equity Type

ORD

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Contact Information

Address 250 Campus Drive
Marlborough, 01752
United States
Phone 508 263 2900
Fax -

Top Executives

Name Age Since Title
Scott T. Garrett 72 2013 Independent Director
Charles J. Dockendorff 68 2017 Independent Director
Ludwig N. Hantson 61 2018 Independent Director
Stacey D. Stewart 60 2023 Independent Director
Nanaz Mohtashami 46 2023 Independent Director
Christiana Stamoulis 53 2011 Independent Director
Sally Wellinghoff Crawford 70 2007 Independent Director
Amy M. Wendell 63 2016 Lead Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HOLX Comments

Write your thoughts about Hologic Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Hamziezar Hamzah
Hamziezar Hamzah Dec 13, 2021 1:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy on Deep.
Makoto Kondo
Makoto Kondo Jun 30, 2021 12:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Chance to buy more??
ENG Dig
ENG Dig Feb 19, 2021 10:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What's happened?
Jeff Bailey
JeffB Jan 27, 2021 4:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
HOLX $72.51 @ Close (Earnings)
Renata Hoffmann
Renata Hoffmann Jan 27, 2021 12:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Let's see what happens after the earnings today...
Hamziezar Hamzah
Hamziezar Hamzah Jan 27, 2021 12:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is the result on your trade?
Renata Hoffmann
Renata Hoffmann Jan 25, 2021 12:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
huh?
Gary Vosganian
Gary Vosganian Jan 05, 2021 5:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Seriously - after hours shed the exact gain for the day ?
Sean Lee
Sean Lee Dec 22, 2020 5:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this be $500 stock. free tip. cheers
Roni Riabtseb
Roni Riabtseb Dec 03, 2020 12:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why only dina writing?
Dina Shabsough
Dina Shabsough Nov 10, 2020 3:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
COVID-19 testing should proceed this winter in all the world regardless one or two or three companies announced successful trials wearing masks is a must
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email